{
    "profile_id": "jos-fleskens-5889ba4",
    "first_name": "Jos",
    "last_name": "Fleskens",
    "sub_title": "Co-Founder, former CEO and shareholder at CFM Pharma & Holding B.V.",
    "profile_picture": "https://media.licdn.com/dms/image/C4E03AQFNEE-sbPQVPQ/profile-displayphoto-shrink_800_800/0/1517713445755?e=1701302400&v=beta&t=9mFifoZy_RQpvI9b2TMGBONYnLiuan2P7QkZitBrAFQ",
    "background_image": null,
    "profile_type": "personal",
    "entity_urn": "ACoAAADcLbgBoX1LNGyjfTyYtQh3Fsu6v6Sj26g",
    "object_urn": 14429624,
    "birth_date": null,
    "summary": "Jos Fleskens: Co - Founder and former CEO ( 2007 - 2018 ) of CFM Pharma & CFM Holding BV, a private Dutch pharmaceutical company with a patented tissue protection and tissue repair technology platform. This platform covers the intravenous administration of VANADIS\u00ae an Organic Vanadium (IV+) Compound of which the beneficial effects have been described in several scientific publications. \n\nPreclinical data of CFM\u2019s drug compound VANADIS\u00ae have demonstrated:\n1: excellent results in preventing ischemic / reperfusion  injury, over 40% reduction of infarct size in Myocardial Infarction, \n2: 90% prevention of tissue damage in Burns, \n3: proven protection characteristics of Kidneys in Trauma setting. \n\nThe preferred vanadium compound VANADIS\u00ae (bis(maltolato)oxovanadium (BMOV)) has a widely known safety profile. \n\nMajor Acomplishments during this period:\nAfter years of persistence and focus, CFM Pharma has been taken to a higher level, which has resulted in a significant step forward that brings a successful completion and exit a lot closer - this under \u201cthe R&D banner\u201d of Professor Li Ming Gan - VP R&D cardiology - AstraZeneca.\n\nProfessor Li Ming Gan has joined CFM as Technical Board Director, he will managing the work within the cardiovascular field regarding the phase 2 study.\n\nThis has resulted that CFM Pharma ( as 2nd foreign company ) has been admitted to AstraZeneca's Bio Venture Hub in Sweden, and move to, and open a CFM Pharma office, in Gothenburg in Sweden.\n\nCompany status;\n\u2022 Preclinical studys required for phase 1 - completed\n\u2022 Clinical phase I ( Vanadis tested in healthy volunteers) - completed\n\u2022 Development of synthesized production formula - completed\n\u2022 Registration of new patents and patent strategy - completed\n\u2022 Protocols for starting phase 2 studies - completed\n\u2022 Strengthen CFM board with Key Opinion Leaders - completed\n\u2022 Strengthen CFM board with strong Technical Expertise -  completed\n\u2022 Leifeng Cheng: ( AstraZeneca ) has joined CFM as Project Director,  Managing pre-clinical and \n   clinical research in the field of heart failure.\n\u2022 Professor Rehder worldwide recognized Vanadium expert joined CFM\u2019s Scientific team - completed\n\u2022 Coorporation with Centres of Exellence in: Cardiology - Burns - Vascular microcirculation\n\u2022 CFM VANADIS study established- with Centers of Exellence, UMC Leiden & Karlinski Gothenburg\n\u2022 Study published in the; International Journal of Molecular Sciences ( high ranking ) \n\u2022 Private investments attracted and STAK established,\n\u2022 Able to collect grants and investment capital - on - going process\n\n\n",
    "location": {
        "country": "Netherlands",
        "short": "Almere, Flevoland",
        "city": "Almere",
        "state": "Flevoland",
        "default": "Almere, Flevoland, Netherlands"
    },
    "premium": false,
    "influencer": false,
    "treasury_media": [],
    "languages": {
        "primary_locale": {
            "country": "US",
            "language": "en"
        },
        "supported_locales": [
            {
                "country": "US",
                "language": "en"
            }
        ],
        "profile_languages": []
    },
    "industry": "Biotechnology",
    "education": [
        {
            "date": {
                "start": {
                    "month": null,
                    "day": null,
                    "year": 1982
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": 1984
                }
            },
            "school": {
                "name": "Academy of The Hague ",
                "logo": null,
                "url": null
            },
            "degree_name": "Bachelor (BA) Staff Degree",
            "field_of_study": "University Hospital Utrecht ( UMC ) Topic: Hospital Management & Organisation",
            "grade": null
        }
    ],
    "patents": [],
    "awards": [],
    "certifications": [],
    "organizations": [],
    "projects": [],
    "publications": [],
    "courses": [],
    "test_scores": [],
    "position_groups": [
        {
            "company": {
                "id": null,
                "name": "CFM Pharma & Holding B.V.",
                "logo": null,
                "url": null,
                "employees": {
                    "start": null,
                    "end": null
                }
            },
            "date": {
                "start": {
                    "month": 1,
                    "day": null,
                    "year": 2007
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": null
                }
            },
            "profile_positions": [
                {
                    "location": "The Netherlands",
                    "date": {
                        "start": {
                            "month": 8,
                            "day": null,
                            "year": 2018
                        },
                        "end": {
                            "month": null,
                            "day": null,
                            "year": null
                        }
                    },
                    "company": "CFM Pharma & Holding B.V.",
                    "description": "After being semi - retired and CEO of CFM Pharma BV for 11 years, I transferred my activities within CFM Pharma to the next generation and therefore have time to do other things, with a strong preference for Biotech and even more for Medtech.",
                    "title": "Co-Founder / shareholder",
                    "employment_type": null
                },
                {
                    "location": "IJsselstein The Netherlands - 2018 Gothenburg Sweden ",
                    "date": {
                        "start": {
                            "month": 1,
                            "day": null,
                            "year": 2007
                        },
                        "end": {
                            "month": 8,
                            "day": null,
                            "year": 2018
                        }
                    },
                    "company": "CFM Pharma & Holding B.V.",
                    "description": "Biographical Sketch:\nName: Jos Fleskens, BA: Former CEO and Co-founder of CFM Pharma & Holding B.V.\nHe was able to make CFM visible and was heavily involved by the admission of CFM to the AstraZeneca BioVentureHub in Sweden, which has resulted in a relocation to/ and opening of the Gothenburg CFM office in August 2018. \n\nHe was formerly CEO of GHO Holding, GHO Clinic ( currently, Hair Science Institute ) and GHO Pharma, a R&D company in inflammation of tissue injury. During this period he was responsible for collecting Investment Capital, Marketing, Business Development, IP, this in corporation with ABN-AMRO Bank Participations Life Science. \n\nGHO received an award for being the \u201cMost Innovative Life Sciences Company\u201d by LIOF, a Dutch Province VC Company. \n\nMr. Fleskens has over 20 years experience in the medical device and life sciences industry and holds a Hospital Management Degree ( BA ) at The Academy of The Hague.\n\nBefore CFM Pharma he worked in the cardiovascular and heamodynamic field in different European management positions, at companies like: Edwards Life Sciences, Baxter and Pulsion, he was accountable for: Education, S&M, Managing P&Ls and Business Development strategy, for introducing of High-Tech Products to Mainstream Customers \n\nManager Europe \nAt Norian Corporation, a start - up orthopedic device company in biomaterials, he was accountable for B&D and establishing the European commercialization of Norian SRS, an Injectable Calcium Phosphate bone Cement. Responsible in the pre launch roll out for Norian SRS in the field of Orthopedics and Traumatology. The strategy of Norian's Head Office US was heavily influenced and guided by the positive results achieved in Europe, what resulted in a sale to Synthes, a global player in Orthopedics.\n \nAt Baxter he was BUM Critical Care Devision and member of the European Medical Critical Care Counsel group, who was responsible for product development, defining European Commercialization and Marketing Strategies.",
                    "title": "CEO - CFM Pharma & Holding B.V. ",
                    "employment_type": null
                }
            ]
        },
        {
            "company": {
                "id": null,
                "name": "Molar",
                "logo": null,
                "url": null,
                "employees": {
                    "start": null,
                    "end": null
                }
            },
            "date": {
                "start": {
                    "month": 1,
                    "day": null,
                    "year": 2008
                },
                "end": {
                    "month": 12,
                    "day": null,
                    "year": 2010
                }
            },
            "profile_positions": [
                {
                    "location": "The Netherlands",
                    "date": {
                        "start": {
                            "month": 1,
                            "day": null,
                            "year": 2008
                        },
                        "end": {
                            "month": 12,
                            "day": null,
                            "year": 2010
                        }
                    },
                    "company": "Molar",
                    "description": "Established Molar, at request of  The ANT ( The Dutch dentist Association ). Developing strong competitive and innovative products in the field of dentists.",
                    "title": "Managing Director Business Development",
                    "employment_type": null
                }
            ]
        },
        {
            "company": {
                "id": 3051,
                "name": "Apollo Group",
                "logo": "https://media.licdn.com/dms/image/C4E0BAQHld7AiOHwA0w/company-logo_400_400/0/1519855863433?e=1703721600&v=beta&t=WgWpLoitKIiyy0V261Mq7wQQRFgPGpRwzjEZQkFqjME",
                "url": "https://www.linkedin.com/company/apollo-group/",
                "employees": {
                    "start": 10001,
                    "end": null
                }
            },
            "date": {
                "start": {
                    "month": 1,
                    "day": null,
                    "year": 2006
                },
                "end": {
                    "month": 12,
                    "day": null,
                    "year": 2007
                }
            },
            "profile_positions": [
                {
                    "location": "The Netherlands",
                    "date": {
                        "start": {
                            "month": 1,
                            "day": null,
                            "year": 2006
                        },
                        "end": {
                            "month": 12,
                            "day": null,
                            "year": 2007
                        }
                    },
                    "company": "Apollo Education Group",
                    "description": "Transformation from a production company to a Business Development Company with a strong Sales & Marketing approach.",
                    "title": "Project management",
                    "employment_type": null
                }
            ]
        },
        {
            "company": {
                "id": null,
                "name": "AirInspace",
                "logo": null,
                "url": null,
                "employees": {
                    "start": null,
                    "end": null
                }
            },
            "date": {
                "start": {
                    "month": null,
                    "day": null,
                    "year": 2003
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": 2005
                }
            },
            "profile_positions": [
                {
                    "location": "The Netherlands - France",
                    "date": {
                        "start": {
                            "month": null,
                            "day": null,
                            "year": 2003
                        },
                        "end": {
                            "month": null,
                            "day": null,
                            "year": 2005
                        }
                    },
                    "company": "AirInspace",
                    "description": "European introduction and commercialization of a new unique innovative technique in Airdecontanimation. ( The Plasmer technique ).\n\nAIRINSPACE was a start-up company in 2003 specializing in air decontamination (making the air free of viruses and bacteria) through an adapted core space technology to needs Healthcare and Transportation markets.\n\nPrimary focus: Implementation of a new brand platform in different indications at University and Military Hospitals, as well setting up a new distribution network Europe.",
                    "title": "European Sales Director",
                    "employment_type": null
                }
            ]
        },
        {
            "company": {
                "id": null,
                "name": "GHO Holding",
                "logo": null,
                "url": null,
                "employees": {
                    "start": null,
                    "end": null
                }
            },
            "date": {
                "start": {
                    "month": 1,
                    "day": null,
                    "year": 2000
                },
                "end": {
                    "month": 4,
                    "day": null,
                    "year": 2003
                }
            },
            "profile_positions": [
                {
                    "location": "The Netherlands",
                    "date": {
                        "start": {
                            "month": 1,
                            "day": null,
                            "year": 2000
                        },
                        "end": {
                            "month": 4,
                            "day": null,
                            "year": 2003
                        }
                    },
                    "company": "GHO Holding",
                    "description": "Building this start up company into a leading, inventive organization with 2 divisions Gho Clinic and Gho Pharma.\n\nGho Clinic, ( currently, Hair Science Institute ): became a leading R&D Company in hair restoration treatment. Clinic developed a new method of hairtransplantation, so called Follicle Transplantation.\n\nGho Pharma: Research & Development company in the medical fields of inflammation and secondary tissue injury, initiated by direct injury such as burns, ischemia and stroke.",
                    "title": "CEO",
                    "employment_type": null
                }
            ]
        },
        {
            "company": {
                "id": 107321,
                "name": "Pulsion Technology",
                "logo": "https://media.licdn.com/dms/image/C4E0BAQEMHV-lFniY5w/company-logo_400_400/0/1570658235360?e=1703721600&v=beta&t=ahNbYCCkSlqUqg81dt0wNEoD4N34Xtf44AvkwyinGKk",
                "url": "https://www.linkedin.com/company/pulsion-technology/",
                "employees": {
                    "start": 11,
                    "end": 50
                }
            },
            "date": {
                "start": {
                    "month": 1,
                    "day": null,
                    "year": 1999
                },
                "end": {
                    "month": 12,
                    "day": null,
                    "year": 2001
                }
            },
            "profile_positions": [
                {
                    "location": "The Netherlands",
                    "date": {
                        "start": {
                            "month": 1,
                            "day": null,
                            "year": 1999
                        },
                        "end": {
                            "month": 12,
                            "day": null,
                            "year": 2001
                        }
                    },
                    "company": "Pulsion Technology",
                    "description": "Pulsion a new German medical device company, specialized in intra thoracol volume measurement. ( lungwater ) \nThe Pulsion technic has been successfully launched in the Netherlands. This new technique has lead to new insights in the treatment of seriously ill patients.",
                    "title": "Managing Director Sales and marketing - The Netherlands",
                    "employment_type": null
                }
            ]
        },
        {
            "company": {
                "id": null,
                "name": "Norian",
                "logo": null,
                "url": null,
                "employees": {
                    "start": null,
                    "end": null
                }
            },
            "date": {
                "start": {
                    "month": 1,
                    "day": null,
                    "year": 1993
                },
                "end": {
                    "month": 10,
                    "day": null,
                    "year": 1999
                }
            },
            "profile_positions": [
                {
                    "location": "The Netherlands - USA",
                    "date": {
                        "start": {
                            "month": 1,
                            "day": null,
                            "year": 1993
                        },
                        "end": {
                            "month": 10,
                            "day": null,
                            "year": 1999
                        }
                    },
                    "company": "Norian",
                    "description": "Norian a new orthopedic start up company in biomaterials.\nThe mission was the establishment of new standards of care for skeletal repair  (Norian SRS \u2013 Skeletal Repair System).\n\t\nAs Manager Europe of Norian Corporation, I was accountable for Business Development and establishing the European commercialization of Norian SRS.\nThe strategy of the Head Office was heavily influenced and guided by the positive results achieved in Europe, what resulted in a sale to Synthes, a global player in Orthopedics.",
                    "title": "Manager Europe ",
                    "employment_type": null
                }
            ]
        },
        {
            "company": {
                "id": null,
                "name": "Baxter International Inc./ Edwards Life Sciences",
                "logo": null,
                "url": null,
                "employees": {
                    "start": null,
                    "end": null
                }
            },
            "date": {
                "start": {
                    "month": null,
                    "day": null,
                    "year": 1985
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": 1993
                }
            },
            "profile_positions": [
                {
                    "location": "The Netherlands",
                    "date": {
                        "start": {
                            "month": null,
                            "day": null,
                            "year": 1985
                        },
                        "end": {
                            "month": null,
                            "day": null,
                            "year": 1993
                        }
                    },
                    "company": "Baxter International Inc./ Edwards Life Sciences",
                    "description": "Sales and Marketing Manager The Netherlands ( Critical Care Division )\nEuropean Sales Supervisor in the field of highly innovative technical products for monitoring hemodynamics.\n\nDuring this period of time I was a Member of the European Critical Care Counsel, ( selected group within Baxter ), Chairman of the European Specialty products Group, Chairman of the Dutch Critical Care Focus Group",
                    "title": "BUM",
                    "employment_type": null
                }
            ]
        }
    ],
    "volunteer_experiences": [],
    "skills": [
        "R&D",
        "New Business Development",
        "International Sales",
        "Direct Sales",
        "Marketing Strategy",
        "Market Research",
        "Entrepreneurship",
        "Business Strategy",
        "Commercial Management",
        "Personal Training",
        "Biotechnology",
        "Pharmaceutical Industry",
        "Lifesciences",
        "Medical Devices",
        "Clinical Research",
        "Clinical Trials"
    ],
    "network_info": null,
    "related_profiles": null,
    "contact_info": null
}